165 related articles for article (PubMed ID: 29403996)
1. Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.
Sapte S; Pore Y
J Pharm Anal; 2016 Oct; 6(5):300-306. PubMed ID: 29403996
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and molecular modeling studies of cefixime-L-arginine-cyclodextrin ternary inclusion compounds.
Jadhav P; Petkar B; Pore Y; Kulkarni A; Burade K
Carbohydr Polym; 2013 Nov; 98(2):1317-25. PubMed ID: 24053809
[TBL] [Abstract][Full Text] [Related]
3. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
4. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
Jablan J; Szalontai G; Jug M
J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
[TBL] [Abstract][Full Text] [Related]
6. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes.
Khan WH; Asghar S; Khan IU; Irfan M; Alshammari A; Riaz Rajoka MS; Munir R; Shah PA; Khalid I; Razzaq FA; Khalid SH
Heliyon; 2023 Sep; 9(9):e19658. PubMed ID: 37809727
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
Ai F; Ma Y; Wang J; Li Y
Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.
Ribeiro LS; Ferreira DC; Veiga FJ
Eur J Pharm Sci; 2003 Nov; 20(3):253-66. PubMed ID: 14592691
[TBL] [Abstract][Full Text] [Related]
10. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
[TBL] [Abstract][Full Text] [Related]
11. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
12. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
13. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
14. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
Fernandes CM; Teresa Vieira M; Veiga FJ
Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
[TBL] [Abstract][Full Text] [Related]
16. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
18. Investigation and physicochemical characterization of clarithromycin-citric acid-cyclodextrins ternary complexes.
Zhang X; Zhang Y; Zhong D; Chen Y; Li S
Drug Dev Ind Pharm; 2007 Feb; 33(2):163-71. PubMed ID: 17454048
[TBL] [Abstract][Full Text] [Related]
19. Ternary system of sultamicillin tosylate with hydroxypropyl-β-cyclodextrin and L-arginine: susceptibility against methicillin-resistant
Bolibol M; Guzman G; De Guzman LM
Ther Deliv; 2022 Dec; 13(12):561-575. PubMed ID: 36861310
[No Abstract] [Full Text] [Related]
20. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]